Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV-1 | 113 | 2024 | 6966 | 10.300 |
Why?
|
Proviruses | 24 | 2024 | 320 | 6.060 |
Why?
|
HIV Infections | 129 | 2024 | 17564 | 5.950 |
Why?
|
CD4-Positive T-Lymphocytes | 57 | 2024 | 4419 | 5.400 |
Why?
|
Virus Latency | 20 | 2024 | 360 | 5.040 |
Why?
|
Viral Load | 40 | 2024 | 3399 | 2.640 |
Why?
|
HIV Seropositivity | 9 | 2023 | 963 | 2.430 |
Why?
|
CD8-Positive T-Lymphocytes | 42 | 2022 | 4642 | 2.250 |
Why?
|
HIV Long-Term Survivors | 9 | 2018 | 140 | 2.170 |
Why?
|
Anti-Retroviral Agents | 20 | 2024 | 1794 | 2.030 |
Why?
|
DNA, Viral | 16 | 2022 | 2206 | 1.910 |
Why?
|
Disease Reservoirs | 8 | 2020 | 123 | 1.550 |
Why?
|
T-Lymphocyte Subsets | 8 | 2022 | 1814 | 1.260 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2014 | 381 | 1.120 |
Why?
|
Anti-HIV Agents | 21 | 2024 | 4567 | 1.100 |
Why?
|
T-Lymphocytes, Helper-Inducer | 5 | 2020 | 977 | 1.080 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2024 | 776 | 1.060 |
Why?
|
Virus Replication | 17 | 2024 | 2459 | 1.050 |
Why?
|
Genome, Viral | 4 | 2020 | 673 | 0.990 |
Why?
|
Viremia | 15 | 2024 | 725 | 0.980 |
Why?
|
Virus Integration | 5 | 2024 | 306 | 0.950 |
Why?
|
Receptors, HIV | 2 | 2017 | 159 | 0.930 |
Why?
|
Interferon-alpha | 5 | 2024 | 909 | 0.920 |
Why?
|
Immunity, Innate | 9 | 2024 | 3080 | 0.840 |
Why?
|
Antiretroviral Therapy, Highly Active | 16 | 2019 | 1903 | 0.820 |
Why?
|
Dendritic Cells | 18 | 2023 | 2757 | 0.780 |
Why?
|
Th1 Cells | 3 | 2020 | 1044 | 0.770 |
Why?
|
T-Lymphocytes, Cytotoxic | 15 | 2022 | 1797 | 0.730 |
Why?
|
Viral Tropism | 2 | 2017 | 102 | 0.680 |
Why?
|
Immunologic Memory | 5 | 2023 | 1375 | 0.640 |
Why?
|
AIDS Vaccines | 8 | 2024 | 900 | 0.620 |
Why?
|
Phylogeny | 5 | 2022 | 2846 | 0.600 |
Why?
|
Acquired Immunodeficiency Syndrome | 9 | 2009 | 2203 | 0.590 |
Why?
|
Histocompatibility Antigens Class I | 10 | 2022 | 1362 | 0.550 |
Why?
|
Killer Cells, Natural | 10 | 2023 | 2209 | 0.530 |
Why?
|
Hydroxamic Acids | 3 | 2016 | 482 | 0.530 |
Why?
|
Hepatitis C | 4 | 2018 | 1594 | 0.530 |
Why?
|
HIV | 6 | 2021 | 1596 | 0.520 |
Why?
|
Humans | 157 | 2024 | 768451 | 0.510 |
Why?
|
Base Sequence | 8 | 2022 | 12428 | 0.500 |
Why?
|
Evolution, Molecular | 5 | 2019 | 1897 | 0.490 |
Why?
|
Cyclin-Dependent Kinase 2 | 2 | 2014 | 185 | 0.480 |
Why?
|
Ribavirin | 3 | 2018 | 395 | 0.470 |
Why?
|
HIV Antibodies | 5 | 2023 | 1341 | 0.460 |
Why?
|
Receptors, Immunologic | 6 | 2014 | 1415 | 0.460 |
Why?
|
Telomerase | 2 | 2010 | 751 | 0.460 |
Why?
|
Leukocytes, Mononuclear | 9 | 2024 | 1855 | 0.450 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2014 | 21 | 0.450 |
Why?
|
Lymph Nodes | 4 | 2023 | 3472 | 0.440 |
Why?
|
HIV Reverse Transcriptase | 1 | 2014 | 214 | 0.430 |
Why?
|
RNA, Viral | 11 | 2024 | 2865 | 0.430 |
Why?
|
CD4 Lymphocyte Count | 11 | 2024 | 2596 | 0.410 |
Why?
|
Receptors, CXCR4 | 1 | 2017 | 729 | 0.410 |
Why?
|
Cell Polarity | 1 | 2015 | 639 | 0.400 |
Why?
|
Monocytes | 5 | 2020 | 2591 | 0.390 |
Why?
|
Epitopes, T-Lymphocyte | 11 | 2021 | 828 | 0.390 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 3 | 2023 | 545 | 0.390 |
Why?
|
Receptors, CCR5 | 3 | 2021 | 490 | 0.380 |
Why?
|
Telomere-Binding Proteins | 1 | 2012 | 122 | 0.370 |
Why?
|
Hematologic Neoplasms | 1 | 2023 | 1905 | 0.370 |
Why?
|
Myeloid Cells | 3 | 2021 | 833 | 0.370 |
Why?
|
Antigen Presentation | 7 | 2012 | 1251 | 0.370 |
Why?
|
Indoles | 3 | 2016 | 1834 | 0.360 |
Why?
|
Botswana | 6 | 2023 | 1059 | 0.360 |
Why?
|
Ritonavir | 2 | 2003 | 330 | 0.350 |
Why?
|
HLA-B Antigens | 5 | 2016 | 328 | 0.350 |
Why?
|
Reverse Transcriptase Inhibitors | 3 | 2020 | 622 | 0.340 |
Why?
|
HIV Protease Inhibitors | 2 | 2003 | 432 | 0.340 |
Why?
|
Daptomycin | 1 | 2009 | 71 | 0.330 |
Why?
|
Heterochromatin | 2 | 2023 | 294 | 0.320 |
Why?
|
Stem Cells | 4 | 2019 | 3538 | 0.320 |
Why?
|
Th17 Cells | 1 | 2015 | 798 | 0.320 |
Why?
|
Antiviral Agents | 6 | 2023 | 3063 | 0.310 |
Why?
|
Flow Cytometry | 11 | 2017 | 5904 | 0.310 |
Why?
|
Transcription, Genetic | 2 | 2022 | 7599 | 0.310 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 712 | 0.310 |
Why?
|
HIV Envelope Protein gp120 | 2 | 2014 | 925 | 0.300 |
Why?
|
Glycopeptides | 1 | 2009 | 220 | 0.300 |
Why?
|
Infectious Disease Transmission, Vertical | 4 | 2024 | 1359 | 0.300 |
Why?
|
HLA-A3 Antigen | 2 | 2006 | 34 | 0.290 |
Why?
|
Phenotype | 2 | 2023 | 16712 | 0.280 |
Why?
|
Chromosomes, Human | 2 | 2019 | 444 | 0.280 |
Why?
|
Adult | 55 | 2024 | 223542 | 0.280 |
Why?
|
Toll-Like Receptor 9 | 2 | 2019 | 199 | 0.280 |
Why?
|
Simian immunodeficiency virus | 3 | 2023 | 814 | 0.280 |
Why?
|
Virus Activation | 3 | 2020 | 322 | 0.270 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2006 | 70 | 0.270 |
Why?
|
Infant, Newborn | 9 | 2024 | 26395 | 0.260 |
Why?
|
Antibodies, Neutralizing | 3 | 2023 | 2008 | 0.260 |
Why?
|
Endocarditis, Bacterial | 1 | 2009 | 438 | 0.250 |
Why?
|
Middle Aged | 47 | 2024 | 223418 | 0.250 |
Why?
|
Female | 61 | 2024 | 396943 | 0.250 |
Why?
|
Male | 58 | 2024 | 364781 | 0.250 |
Why?
|
Cell Survival | 6 | 2023 | 5801 | 0.240 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5709 | 0.240 |
Why?
|
Cell Proliferation | 8 | 2024 | 10494 | 0.240 |
Why?
|
Genes, nef | 1 | 2004 | 52 | 0.240 |
Why?
|
Down-Regulation | 1 | 2012 | 2944 | 0.230 |
Why?
|
Hemophilia B | 1 | 2005 | 83 | 0.230 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2014 | 1355 | 0.230 |
Why?
|
Immunity, Cellular | 5 | 2015 | 1561 | 0.220 |
Why?
|
Leukocytes | 1 | 2011 | 2030 | 0.220 |
Why?
|
Receptors, Chemokine | 2 | 2007 | 655 | 0.220 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 3 | 2022 | 808 | 0.220 |
Why?
|
Interferon-gamma | 7 | 2015 | 3169 | 0.210 |
Why?
|
Receptors, Interleukin-21 | 1 | 2023 | 32 | 0.210 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3665 | 0.210 |
Why?
|
Mozambique | 1 | 2022 | 55 | 0.210 |
Why?
|
Liver Failure | 1 | 2005 | 252 | 0.210 |
Why?
|
Interleukins | 3 | 2017 | 792 | 0.210 |
Why?
|
Alleles | 7 | 2022 | 6890 | 0.210 |
Why?
|
Membrane Glycoproteins | 6 | 2014 | 3713 | 0.210 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 4 | 2014 | 149 | 0.200 |
Why?
|
Ionomycin | 1 | 2022 | 110 | 0.200 |
Why?
|
Sequence Analysis, DNA | 3 | 2022 | 4780 | 0.200 |
Why?
|
Drug Resistance, Bacterial | 1 | 2009 | 1064 | 0.200 |
Why?
|
Indinavir | 1 | 2002 | 73 | 0.200 |
Why?
|
Sarcoma, Kaposi | 1 | 2005 | 374 | 0.200 |
Why?
|
B-Lymphocyte Subsets | 1 | 2023 | 240 | 0.190 |
Why?
|
Gene Products, gag | 4 | 2007 | 318 | 0.190 |
Why?
|
Hemophilia A | 1 | 2005 | 359 | 0.190 |
Why?
|
Delusions | 1 | 2024 | 301 | 0.190 |
Why?
|
Molecular Sequence Data | 13 | 2014 | 17647 | 0.190 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2005 | 679 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 9 | 2 | 2011 | 68 | 0.190 |
Why?
|
Antigens, CD | 6 | 2015 | 4029 | 0.180 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2022 | 826 | 0.180 |
Why?
|
Basal Ganglia | 1 | 2023 | 555 | 0.180 |
Why?
|
Heterocyclic Compounds, 3-Ring | 2 | 2020 | 295 | 0.180 |
Why?
|
Species Specificity | 4 | 2014 | 2422 | 0.180 |
Why?
|
Genes, MHC Class I | 4 | 2010 | 236 | 0.180 |
Why?
|
Staphylococcal Infections | 1 | 2009 | 1412 | 0.180 |
Why?
|
Lymphocyte Activation | 5 | 2020 | 5495 | 0.180 |
Why?
|
Infant | 9 | 2024 | 36497 | 0.170 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2000 | 141 | 0.170 |
Why?
|
Up-Regulation | 4 | 2014 | 4138 | 0.170 |
Why?
|
HLA Antigens | 3 | 2011 | 1338 | 0.170 |
Why?
|
Integrins | 2 | 2024 | 845 | 0.170 |
Why?
|
Lectins, C-Type | 1 | 2003 | 589 | 0.170 |
Why?
|
Gene Expression Profiling | 5 | 2020 | 9507 | 0.160 |
Why?
|
Acute Disease | 7 | 2019 | 7246 | 0.160 |
Why?
|
Cells, Cultured | 8 | 2020 | 19041 | 0.160 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2000 | 225 | 0.160 |
Why?
|
Lymphocyte Subsets | 2 | 2014 | 313 | 0.160 |
Why?
|
Amino Acid Sequence | 13 | 2014 | 13452 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 167 | 0.160 |
Why?
|
Pyrimidinones | 2 | 2019 | 387 | 0.150 |
Why?
|
Doxorubicin | 1 | 2005 | 2229 | 0.150 |
Why?
|
Helicobacter pylori | 1 | 2002 | 382 | 0.150 |
Why?
|
Clone Cells | 1 | 2022 | 1672 | 0.150 |
Why?
|
Helicobacter Infections | 1 | 2002 | 392 | 0.150 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2002 | 664 | 0.150 |
Why?
|
Antigens, CD34 | 1 | 2000 | 656 | 0.150 |
Why?
|
South Africa | 2 | 2024 | 1870 | 0.150 |
Why?
|
Germinal Center | 1 | 2020 | 379 | 0.150 |
Why?
|
Hepatitis C, Chronic | 2 | 2002 | 1031 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2020 | 4362 | 0.140 |
Why?
|
DNA Mutational Analysis | 2 | 2019 | 4120 | 0.140 |
Why?
|
Cell Adhesion Molecules | 1 | 2003 | 1615 | 0.140 |
Why?
|
Interferons | 2 | 2022 | 714 | 0.130 |
Why?
|
Fatty Liver | 1 | 2003 | 807 | 0.130 |
Why?
|
Biological Evolution | 1 | 2022 | 1081 | 0.130 |
Why?
|
Gene Silencing | 2 | 2020 | 1503 | 0.130 |
Why?
|
Gene Products, nef | 2 | 2006 | 102 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2020 | 867 | 0.120 |
Why?
|
Vaccines, Subunit | 2 | 2014 | 159 | 0.120 |
Why?
|
Aged | 16 | 2022 | 171520 | 0.120 |
Why?
|
Drug Administration Schedule | 4 | 2018 | 4861 | 0.120 |
Why?
|
Reverse Transcription | 1 | 2014 | 48 | 0.120 |
Why?
|
Young Adult | 11 | 2020 | 60045 | 0.120 |
Why?
|
DNA | 2 | 2019 | 7213 | 0.120 |
Why?
|
T-Lymphocytes | 3 | 2017 | 10273 | 0.120 |
Why?
|
Caspase 8 | 1 | 2014 | 198 | 0.110 |
Why?
|
HIV Antigens | 2 | 2005 | 328 | 0.110 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 797 | 0.110 |
Why?
|
Immunodominant Epitopes | 5 | 2006 | 243 | 0.110 |
Why?
|
Cohort Studies | 14 | 2018 | 41797 | 0.110 |
Why?
|
Enzyme Stability | 1 | 2014 | 220 | 0.110 |
Why?
|
Cell Count | 2 | 2015 | 1835 | 0.110 |
Why?
|
Depsipeptides | 1 | 2014 | 96 | 0.110 |
Why?
|
Host-Pathogen Interactions | 3 | 2021 | 1465 | 0.110 |
Why?
|
Toll-Like Receptor 1 | 1 | 2013 | 48 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2007 | 2568 | 0.110 |
Why?
|
Phosphopeptides | 1 | 2014 | 240 | 0.110 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 2819 | 0.110 |
Why?
|
Lipopeptides | 1 | 2013 | 71 | 0.110 |
Why?
|
Case-Control Studies | 6 | 2024 | 22293 | 0.110 |
Why?
|
Disease Progression | 8 | 2017 | 13655 | 0.110 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 506 | 0.100 |
Why?
|
Polyethylene Glycols | 1 | 2018 | 1195 | 0.100 |
Why?
|
HLA-DR Antigens | 2 | 2012 | 607 | 0.100 |
Why?
|
Liver | 2 | 2005 | 7575 | 0.100 |
Why?
|
Polymerase Chain Reaction | 6 | 2020 | 6091 | 0.100 |
Why?
|
Rectum | 1 | 2017 | 902 | 0.100 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 120 | 0.100 |
Why?
|
Genotype | 4 | 2021 | 13047 | 0.100 |
Why?
|
Time Factors | 6 | 2019 | 40271 | 0.100 |
Why?
|
Drug Therapy, Combination | 5 | 2006 | 6320 | 0.090 |
Why?
|
Toll-Like Receptor 2 | 1 | 2013 | 348 | 0.090 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3826 | 0.090 |
Why?
|
RNA, Small Interfering | 4 | 2015 | 3437 | 0.090 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2014 | 1543 | 0.090 |
Why?
|
Nevirapine | 2 | 2023 | 273 | 0.090 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7471 | 0.090 |
Why?
|
Histone Deacetylases | 1 | 2015 | 717 | 0.090 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 381 | 0.090 |
Why?
|
DNA Primers | 3 | 2011 | 2826 | 0.090 |
Why?
|
RNA, Messenger | 4 | 2011 | 12813 | 0.090 |
Why?
|
Prospective Studies | 5 | 2024 | 54914 | 0.090 |
Why?
|
Genetic Variation | 4 | 2019 | 6610 | 0.090 |
Why?
|
Receptors, CXCR5 | 2 | 2023 | 88 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1600 | 0.090 |
Why?
|
Chromatin | 1 | 2022 | 2969 | 0.090 |
Why?
|
Th2 Cells | 1 | 2015 | 1079 | 0.090 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2039 | 0.080 |
Why?
|
Cytokines | 5 | 2017 | 7449 | 0.080 |
Why?
|
HLA-A Antigens | 2 | 2006 | 225 | 0.080 |
Why?
|
Immunophenotyping | 3 | 2014 | 1869 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2013 | 1196 | 0.080 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2863 | 0.070 |
Why?
|
Child | 7 | 2024 | 80863 | 0.070 |
Why?
|
Apoptosis | 2 | 2018 | 9526 | 0.070 |
Why?
|
HLA-B27 Antigen | 1 | 2007 | 66 | 0.070 |
Why?
|
Disease Transmission, Infectious | 1 | 2013 | 562 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2000 | 3408 | 0.070 |
Why?
|
Oxazines | 2 | 2020 | 357 | 0.070 |
Why?
|
Inflammation | 2 | 2024 | 10865 | 0.070 |
Why?
|
International Cooperation | 1 | 2014 | 1439 | 0.070 |
Why?
|
RNA Polymerase II | 1 | 2011 | 547 | 0.070 |
Why?
|
Withholding Treatment | 2 | 2024 | 621 | 0.070 |
Why?
|
Mutation | 7 | 2021 | 30243 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2014 | 2731 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4586 | 0.070 |
Why?
|
Adjuvants, Immunologic | 1 | 2012 | 998 | 0.070 |
Why?
|
Phosphorylation | 2 | 2014 | 8332 | 0.070 |
Why?
|
Drug Resistance, Viral | 2 | 2021 | 869 | 0.070 |
Why?
|
Cell Degranulation | 1 | 2007 | 277 | 0.060 |
Why?
|
B-Lymphocytes | 4 | 2020 | 4781 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2017 | 3048 | 0.060 |
Why?
|
Diseases in Twins | 1 | 2007 | 447 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2019 | 14766 | 0.060 |
Why?
|
MicroRNAs | 1 | 2021 | 3805 | 0.060 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2005 | 152 | 0.060 |
Why?
|
HLA-A2 Antigen | 1 | 2005 | 209 | 0.060 |
Why?
|
Pyridones | 2 | 2020 | 819 | 0.060 |
Why?
|
Child, Preschool | 6 | 2024 | 42623 | 0.060 |
Why?
|
Viral Structural Proteins | 1 | 2004 | 94 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2007 | 660 | 0.060 |
Why?
|
Ligands | 2 | 2008 | 3281 | 0.060 |
Why?
|
Gene Expression Regulation | 4 | 2020 | 11930 | 0.060 |
Why?
|
Cross Reactions | 1 | 2006 | 828 | 0.060 |
Why?
|
Lamivudine | 2 | 2021 | 368 | 0.060 |
Why?
|
Signal Transduction | 4 | 2021 | 23638 | 0.060 |
Why?
|
Interleukin-12 | 2 | 2020 | 578 | 0.060 |
Why?
|
Immunoglobulin D | 1 | 2023 | 55 | 0.050 |
Why?
|
Amino Acid Substitution | 2 | 2006 | 1744 | 0.050 |
Why?
|
Zidovudine | 2 | 2021 | 625 | 0.050 |
Why?
|
RNA | 2 | 2023 | 2727 | 0.050 |
Why?
|
Interleukin-2 | 2 | 2014 | 1894 | 0.050 |
Why?
|
Genes, Viral | 1 | 2004 | 654 | 0.050 |
Why?
|
HIV-2 | 1 | 2023 | 156 | 0.050 |
Why?
|
Hepatomegaly | 1 | 2003 | 84 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2008 | 1152 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 185 | 0.050 |
Why?
|
RNA Interference | 1 | 2011 | 2832 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2012 | 2434 | 0.050 |
Why?
|
Immune Tolerance | 1 | 2012 | 2326 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Receptors, CCR1 | 1 | 2002 | 30 | 0.050 |
Why?
|
Lung Diseases, Fungal | 1 | 2003 | 125 | 0.050 |
Why?
|
Gene Expression | 1 | 2015 | 7605 | 0.050 |
Why?
|
Chemokine CCL3 | 1 | 2002 | 85 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
CD4-CD8 Ratio | 1 | 2002 | 114 | 0.050 |
Why?
|
Chemokine CCL4 | 1 | 2002 | 127 | 0.050 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2002 | 122 | 0.050 |
Why?
|
Receptors, CCR4 | 1 | 2002 | 77 | 0.050 |
Why?
|
Tandem Repeat Sequences | 1 | 2003 | 182 | 0.050 |
Why?
|
Mitochondria, Liver | 1 | 2003 | 191 | 0.050 |
Why?
|
Telomere | 1 | 2008 | 943 | 0.050 |
Why?
|
Transaminases | 1 | 2003 | 199 | 0.050 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 2 | 2018 | 215 | 0.050 |
Why?
|
Ileum | 1 | 2024 | 558 | 0.050 |
Why?
|
Receptors, CXCR3 | 2 | 2017 | 240 | 0.050 |
Why?
|
Caspase 3 | 1 | 2004 | 732 | 0.050 |
Why?
|
Cross-Sectional Studies | 5 | 2017 | 26351 | 0.050 |
Why?
|
Chemokine CCL5 | 1 | 2002 | 214 | 0.050 |
Why?
|
Macaca mulatta | 2 | 2019 | 2363 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3708 | 0.050 |
Why?
|
Liposomes | 1 | 2005 | 792 | 0.050 |
Why?
|
Proteins | 1 | 2016 | 6008 | 0.050 |
Why?
|
Argentina | 1 | 2021 | 248 | 0.050 |
Why?
|
Caspases | 1 | 2004 | 884 | 0.050 |
Why?
|
Boston | 1 | 2014 | 9361 | 0.050 |
Why?
|
HIV Core Protein p24 | 2 | 2014 | 247 | 0.050 |
Why?
|
Animals | 7 | 2023 | 169418 | 0.040 |
Why?
|
Nucleotidyltransferases | 1 | 2022 | 243 | 0.040 |
Why?
|
DNA, Satellite | 1 | 2020 | 67 | 0.040 |
Why?
|
Linear Models | 3 | 2016 | 5880 | 0.040 |
Why?
|
Epitopes | 4 | 2010 | 2526 | 0.040 |
Why?
|
Integrin alpha4beta1 | 1 | 2000 | 119 | 0.040 |
Why?
|
STAT4 Transcription Factor | 1 | 2020 | 94 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2020 | 189 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 190 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2004 | 1775 | 0.040 |
Why?
|
Mycoses | 1 | 2003 | 386 | 0.040 |
Why?
|
Drug Design | 1 | 2005 | 1050 | 0.040 |
Why?
|
Nausea | 1 | 2003 | 682 | 0.040 |
Why?
|
Culicidae | 1 | 2020 | 110 | 0.040 |
Why?
|
Pregnancy | 4 | 2024 | 30179 | 0.040 |
Why?
|
Centromere | 1 | 2020 | 215 | 0.040 |
Why?
|
CREB-Binding Protein | 1 | 2019 | 147 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 18048 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2018 | 6527 | 0.040 |
Why?
|
Germany | 1 | 2002 | 882 | 0.040 |
Why?
|
Vomiting | 1 | 2003 | 655 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2020 | 350 | 0.040 |
Why?
|
Piperazines | 2 | 2020 | 2546 | 0.040 |
Why?
|
Alkynes | 1 | 2020 | 327 | 0.040 |
Why?
|
Remission Induction | 1 | 2005 | 2408 | 0.040 |
Why?
|
Surface Properties | 1 | 2002 | 1168 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 3108 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39430 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 501 | 0.040 |
Why?
|
AIDS Serodiagnosis | 1 | 2020 | 220 | 0.040 |
Why?
|
Treatment Outcome | 6 | 2019 | 65409 | 0.040 |
Why?
|
Cyclopropanes | 1 | 2020 | 437 | 0.040 |
Why?
|
Defective Viruses | 1 | 2018 | 89 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 3816 | 0.040 |
Why?
|
Benzoxazines | 1 | 2020 | 321 | 0.040 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2000 | 692 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 1100 | 0.040 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2017 | 27 | 0.040 |
Why?
|
Endothelium | 1 | 2000 | 768 | 0.040 |
Why?
|
Algorithms | 2 | 2020 | 14158 | 0.040 |
Why?
|
Lactic Acid | 1 | 2003 | 1140 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2012 | 12450 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2000 | 631 | 0.040 |
Why?
|
Cercocebus atys | 1 | 2017 | 12 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10358 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 16029 | 0.030 |
Why?
|
Viral Proteins | 1 | 2004 | 1803 | 0.030 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 117 | 0.030 |
Why?
|
Glycolysis | 1 | 2021 | 838 | 0.030 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2017 | 85 | 0.030 |
Why?
|
Spain | 1 | 2018 | 491 | 0.030 |
Why?
|
Peptides | 2 | 2010 | 4368 | 0.030 |
Why?
|
Leukemia, T-Cell | 1 | 2017 | 101 | 0.030 |
Why?
|
Magnesium | 1 | 2000 | 816 | 0.030 |
Why?
|
Receptors, CCR6 | 1 | 2017 | 74 | 0.030 |
Why?
|
Brain | 1 | 2023 | 27438 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2000 | 1343 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2003 | 1070 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5042 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2013 | 81834 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2076 | 0.030 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2016 | 126 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1840 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2018 | 752 | 0.030 |
Why?
|
Ubiquitins | 1 | 2017 | 367 | 0.030 |
Why?
|
Neonatal Screening | 1 | 2020 | 618 | 0.030 |
Why?
|
Cyclin A | 1 | 2014 | 60 | 0.030 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2015 | 510 | 0.030 |
Why?
|
Outpatients | 1 | 2003 | 1607 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15609 | 0.030 |
Why?
|
beta Catenin | 1 | 2019 | 1048 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3234 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 792 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2017 | 825 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2298 | 0.030 |
Why?
|
Gene Products, tat | 1 | 2014 | 111 | 0.030 |
Why?
|
Epitope Mapping | 2 | 2005 | 300 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2079 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2000 | 3103 | 0.030 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2014 | 146 | 0.030 |
Why?
|
Chronic Disease | 2 | 2005 | 9382 | 0.030 |
Why?
|
Adolescent | 3 | 2013 | 89168 | 0.030 |
Why?
|
Bystander Effect | 1 | 2013 | 90 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2017 | 1083 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4249 | 0.030 |
Why?
|
Medication Adherence | 1 | 2024 | 2190 | 0.030 |
Why?
|
Calibration | 1 | 2014 | 823 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 2014 | 622 | 0.020 |
Why?
|
Hepacivirus | 1 | 2018 | 1342 | 0.020 |
Why?
|
Biopsy | 1 | 2003 | 6816 | 0.020 |
Why?
|
Survival Rate | 1 | 2005 | 12875 | 0.020 |
Why?
|
Proteomics | 1 | 2024 | 3901 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2959 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2019 | 11674 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1608 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1621 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1628 | 0.020 |
Why?
|
Mothers | 1 | 2020 | 2210 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2987 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 1602 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8510 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3594 | 0.020 |
Why?
|
Solubility | 1 | 2010 | 1086 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8908 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1557 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20231 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2020 | 2181 | 0.020 |
Why?
|
Protein Binding | 1 | 2000 | 9376 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2016 | 3735 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2005 | 15965 | 0.020 |
Why?
|
Comorbidity | 1 | 2002 | 10601 | 0.020 |
Why?
|
Stavudine | 1 | 2006 | 85 | 0.020 |
Why?
|
Antigenic Variation | 1 | 2006 | 118 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2531 | 0.020 |
Why?
|
Kinetics | 1 | 2014 | 6348 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2013 | 1797 | 0.020 |
Why?
|
Twins, Monozygotic | 1 | 2007 | 472 | 0.020 |
Why?
|
Homeostasis | 1 | 2017 | 3351 | 0.020 |
Why?
|
Gene Products, vpr | 1 | 2005 | 33 | 0.020 |
Why?
|
vpr Gene Products, Human Immunodeficiency Virus | 1 | 2005 | 36 | 0.020 |
Why?
|
Risk Factors | 2 | 2024 | 74915 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4534 | 0.020 |
Why?
|
Consensus Sequence | 1 | 2005 | 363 | 0.020 |
Why?
|
Lysosomal-Associated Membrane Protein 1 | 1 | 2004 | 25 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14728 | 0.010 |
Why?
|
Cell Movement | 1 | 2017 | 5223 | 0.010 |
Why?
|
Histocompatibility Testing | 1 | 2006 | 716 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5455 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2017 | 2260 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59680 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8051 | 0.010 |
Why?
|
Aspergillus niger | 1 | 2003 | 18 | 0.010 |
Why?
|
Aspergillus flavus | 1 | 2003 | 14 | 0.010 |
Why?
|
Scedosporium | 1 | 2003 | 10 | 0.010 |
Why?
|
Lung | 1 | 2022 | 10090 | 0.010 |
Why?
|
Fusarium | 1 | 2003 | 51 | 0.010 |
Why?
|
Aspergillus | 1 | 2003 | 95 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2005 | 793 | 0.010 |
Why?
|
Thermodynamics | 1 | 2004 | 594 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2014 | 5152 | 0.010 |
Why?
|
Aspergillus fumigatus | 1 | 2003 | 158 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5909 | 0.010 |
Why?
|
Vaccination | 1 | 2014 | 3434 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2005 | 1164 | 0.010 |
Why?
|
Aspergillosis | 1 | 2003 | 242 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2003 | 762 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8753 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2004 | 1497 | 0.010 |
Why?
|
Selection, Genetic | 1 | 2004 | 877 | 0.010 |
Why?
|
Autopsy | 1 | 2003 | 1013 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2003 | 20762 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 13497 | 0.010 |
Why?
|
China | 1 | 2004 | 2398 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4941 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9263 | 0.010 |
Why?
|
Liver Diseases | 1 | 2002 | 1307 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2006 | 12561 | 0.010 |
Why?
|
Pilot Projects | 1 | 2002 | 8730 | 0.010 |
Why?
|